 |
|
|
| |
Peginterferon Lambda-1A (Lambda) Compared
With Peginterferon Alfa-2A (Alfa) in Treatment-
Naive Patients With HCV Genotypes 2 or 3: First
SVR24 Results From EMERGE Phase IIb
|
| |
| |
Reported by Jules Levin
S Zeuzem, S Arora, B Bacon, T Box, M Charlton, M Diago, D Dieterich,
R Esteban Mur, G Everson, M Fallon, P Ferenci, R Flisiak, J George, R Ghalib,
N Gitlin, A Gladysz, S Gordon, S Greenbloom, T Hassanein, I Jacobson, L Jeffers, K Kowdley, E Lawitz, S Lee, B Leggett, S Lueth, D Nelson, P Pockros, M Rodriguez-Torres, V Rustgi, L Serfaty, M Sherman, M Shiffman, R Sola, M Sulkowski, H Vargas, J Vierling, B Yoffe, L Ishak, D Fontana, D Xu, J Lester, T Gray, A Horga, J Hillson, JC Lopez-Talavera, A Muir, on behalf of the EMERGE Study Group
47th EASL Congress, Barcelona, Spain
April 18-22, 2012
Oral Abstract 1435
|
| |
|
|
|
|
|
